List of Aduro Biotech patents

Patents where

Current Assignee

Name

Aduro Biotech

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7731648 Magnetic nanoscale particle compositions, and therapeutic methods related thereto	Patent 7731648 was granted and assigned to Aduro Biotech on June, 2010 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	7731648	June 8, 2010
‌ US Patent 7842289 Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof	Patent 7842289 was granted and assigned to Aduro Biotech on November, 2010 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	7842289	November 30, 2010
‌ US Patent 10449211 Compositions and methods for activating “stimulator of interferon gene”—dependent signalling	Patent 10449211 was granted and assigned to Aduro Biotech on October, 2019 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	10449211	October 22, 2019
‌ US Patent 9511129 Facultatively attenuated bacterial species and methods of preparation and use thereof	Patent 9511129 was granted and assigned to Aduro Biotech on December, 2016 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	9511129	December 6, 2016
‌ US Patent 9695212 Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use	Patent 9695212 was granted and assigned to Aduro Biotech on July, 2017 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	9695212	July 4, 2017
‌ US Patent 7833775 Modified free-living microbes, vaccine compositions and methods of use thereof	Patent 7833775 was granted and assigned to Aduro Biotech on November, 2010 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	7833775	November 16, 2010
‌ US Patent 7695725 Modified free-living microbes, vaccine compositions and methods of use thereof	Patent 7695725 was granted and assigned to Aduro Biotech on April, 2010 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	7695725	April 13, 2010
‌ US Patent 9549944 Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling	Patent 9549944 was granted and assigned to Aduro Biotech on January, 2017 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	9549944	January 24, 2017
‌ US Patent 8926993 Methods and compositions using	Patent 8926993 was granted and assigned to Aduro Biotech on January, 2015 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	8926993	January 6, 2015
‌ US Patent 9198960 Methods and compositions using listeria for enhancing immunogenicity by prime boost	Patent 9198960 was granted and assigned to Aduro Biotech on December, 2015 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	9198960	December 1, 2015
‌ US Patent 9161974 Methods and compositions using listeria for adjuvant treatment of cancer	Patent 9161974 was granted and assigned to Aduro Biotech on October, 2015 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	9161974	October 20, 2015
‌ US Patent 7935804 Engineered	Patent 7935804 was granted and assigned to Aduro Biotech on May, 2011 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	7935804	May 3, 2011
‌ US Patent 10414789 Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use	Patent 10414789 was granted and assigned to Aduro Biotech on September, 2019 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	10414789	September 17, 2019
‌ US Patent 9663557 Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof	Patent 9663557 was granted and assigned to Aduro Biotech on May, 2017 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	9663557	May 30, 2017
‌ US Patent 10189873 Compositions and methods for inhibiting “stimulator of interferon gene”-dependent signalling	Patent 10189873 was granted and assigned to Aduro Biotech on January, 2019 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	10189873	January 29, 2019
‌ US Patent 7927606 Modified free-living microbes, vaccine compositions and methods of use thereof	Patent 7927606 was granted and assigned to Aduro Biotech on April, 2011 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	7927606	April 19, 2011
‌ US Patent 9878024 Methods and compositions using	Patent 9878024 was granted and assigned to Aduro Biotech on January, 2018 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	9878024	January 30, 2018
‌ US Patent 10738056 Pyrazolopyrimidinone compounds and uses thereof		Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	10738056	August 11, 2020
‌ US Patent 10105427 Epidermal growth factor receptor variant III-mesothelin fusions and methods of using the same	Patent 10105427 was granted and assigned to Aduro Biotech on October, 2018 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	10105427	October 23, 2018
‌ US Patent 9764013 Engineered	Patent 9764013 was granted and assigned to Aduro Biotech on September, 2017 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	9764013	September 19, 2017
‌ US Patent 10526609 Protein expression enhancer sequences and use thereof	Patent 10526609 was granted and assigned to Aduro Biotech on January, 2020 by the United States Patent and Trademark Office.	Aduro Biotech	Aduro Biotech	United States Patent and Trademark Office	10526609	January 7, 2020
‌ US Patent 8287883 None	Patent 8287883 was granted and assigned to Aduro Biotech on October, 2012 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	8287883	October 16, 2012
‌ US Patent 8580939 Engineered Listeria and methods of use thereof	Patent 8580939 was granted and assigned to Aduro Biotech on November, 2013 by the United States Patent and Trademark Office.		Aduro Biotech	United States Patent and Trademark Office	8580939	November 12, 2013

23 results

0 selected

23 results

0 selected